Cancer drugs rejected by the NHS have been found to be effective - The Times 2nd June 2008

Two cancer drugs not available to NHS patients have been shown to improve survival rates significantly, trial results suggest. Avastin, a bowel cancer drug, was rejected by the National Institute for Health and Clinical Excellence, which ruled that it was not good value, while Sutent, a kidney cancer drug, has been turned down by the Scottish Medicines Consortium. Studies reported at the American Society of Clinical Oncology’s annual meeting in Chicago indicate that both drugs are effective.

Link to Article

Additional Story

New drug gives thousands of kidney cancer sufferers new hope at £2,000 a month - Daily Mail 1st June 2008